Hemoblastoses represent two broad groups of malignant blood pathologies, both bone marrow and extramedullary, characterized by the development of hematopoietic function disorders, immunodeficiency, anemia, and hemorrhagic syndrome in patients. Treatment of hemoblastoses in Israel is conducted by oncologists who are respected in the international medical community and possess extensive clinical experience in operational diagnostics and the development of effective therapy schemes. The innovative methods of targeted therapy, adaptive CAR-T cell therapy, and the latest low-toxicity chemotherapy drugs allow for achieving sustained remission in most cases, and in some types of hemoblastoses, complete recovery of the patient.
Early treatment significantly improves prognosis, alleviates symptoms, and greatly enhances the quality of life for patients. The modern high-precision equipment of Israeli clinics, along with advanced methodologies for instrumental and laboratory research, ensures prompt and accurate diagnosis and the selection of the most effective treatment methods and medications for each patient. Patient reviews confirm noticeable improvements shortly after treatment begins, highlighting the reasonable cost of services and a high level of comfort.
Treatment Methods for Diseases
Hemoblastoses are primary malignant pathologies of the hematopoietic and lymphatic systems. In recent years, the incidence of hemoblastoses has been steadily increasing worldwide, currently ranking fifth among all types of oncological diseases. According to statistical studies, this pathology is more common in men, with rural populations being less affected than urban residents.
Hemoblastoses are divided into two major groups:
- leukemias — oncological diseases of hematopoietic tissue characterized by bone marrow involvement;
- hematosarcomas (lymphomas) — extramedullary tumors, most often developing in lymph nodes.
As the disease progresses, various forms of hemoblastoses may transform into one another. For instance, in the development of leukemias, malignant cells can spread to lymph nodes, while in hematosarcomas, the pathological process may involve the bone marrow, leading to changes in blood composition characteristic of leukemia. Acute and chronic types of leukemias are distinguished, while hematosarcomas include Hodgkin's lymphoma and non-Hodgkin lymphomas.
Numerous studies have not been able to determine the exact causes of hemoblastoses. However, it is known that the risk of developing the pathology significantly increases with exposure to ionizing and ultraviolet radiation, including undergoing courses of radiotherapy and radiological diagnostic procedures. Chemical carcinogens that stimulate the onset of hemoblastoses include compounds such as benzene and certain medications. The likelihood of developing the disease increases in cases of conditions based on genetic and chromosomal mutations, viral infections, and metabolic disorders.
The symptoms of hemoblastoses are quite diverse, with typical signs including hemorrhagic syndrome, anemia, increased fatigue, weakness, and sweating. Patients often experience nasal and intestinal bleeding, as well as bleeding gums. As a result of the formation of an immunodeficient state, patients have reduced resistance to infectious diseases, with infections developing rapidly and severely.
Israeli oncologists use modern treatment methods for hemoblastoses tailored based on the patient's diagnostic examination data. When developing a therapy program, the presence of genetic mutations, the stage of the disease, and the overall condition of the patient are taken into account.
Chemotherapy
To eliminate the maximum number of malignant cells, the first stage of treatment includes high-dose polychemotherapy. Chemotherapy drugs are most often administered intravenously, although intrathecal (into the spinal canal) administration is also possible. Once stable remission is achieved, the patient is prescribed maintenance chemotherapy courses, during which low doses of chemotherapy drugs are administered.
Radiotherapy
External radiation of the malignant focus prevents the chaotic division of cancer cells, helps alleviate pain syndrome, and reduces swelling. In neuroleukemia, ionizing radiation affects the brain structures responsible for cerebrospinal fluid production, as well as certain areas of the cervical spine. In Israel, radiotherapy sessions are performed on modern equipment that allows for precise targeting of the tumor surface while minimally affecting normal tissues.
Targeted Therapy
The principle of action of targeted drugs used for treating hemoblastoses lies in the accurate recognition and suppression of the synthesis and activity of oncogenic enzymes. As a result, essential metabolic processes are blocked exclusively in cancer cells. Gradually, the population of tumor cells dies off, while the unaffected cells recover. Targeted therapy does not cause side effects, making it recommended for weakened patients.
CAR-T Therapy
This innovative immunotherapy method was recently introduced into the practice of treating hemoblastoses. The technique is based on developing the ability of the patient's T-lymphocytes to rapidly recognize the cells of the tumor. Modifications of the patient's T-lymphocytes are carried out using genetic engineering laboratory techniques. Since CAR-T therapy is associated with the development of side effects, it is not prescribed for weakened elderly patients. However, its application in children ensures sustained remission in more than 92% of cases.
Bone Marrow Transplantation
The procedure is conducted in two stages. Initially, the patient is given high-dose chemotherapy, leading to complete suppression of the hematopoietic system, after which either autologous (autotransplantation) or donor (allotransplantation) bone marrow transplantation is performed.
Surgical Treatment
This typically forms part of the symptomatic therapy program for lymphomas. Surgical intervention is indicated in cases where lymphoid tissue compresses major blood vessels, nerves, or internal organs.
Supportive Therapy
Symptomatic medication treatment is conducted using the following drugs:
- antibiotics;
- steroid hormones;
- antiemetics;
- metabolic drugs;
- vitamin and mineral complexes.
Send your records — an Ichilov physician will reply within 1–2 days, free of charge.
Diagnostic Methods for Diseases
In Israeli clinics, patient examination and treatment planning takes about three days.
Upon entering the clinic, the patient meets with a leading oncologist. During the consultation, the doctor reviews the medical history and provided results of previous studies, conducts a physical examination, and compiles a list of necessary examinations.
The next day, the types of diagnostic procedures listed are performed:
- complete blood count;
- detection of specific tumor markers in the blood;
- molecular genetic tests;
- bone marrow biopsy;
- imaging studies (X-ray, CT, MRI, PET-CT);
- ultrasound;
- scintigraphy.
The results of the studies are reviewed by a medical council consisting of an oncologist and specialized experts. The doctors collectively establish the final diagnosis and prescribe treatment.
How Much Does Treatment Cost
Most patients are interested in the cost of the treatment course and its affordability. Treatment in Israeli clinics provides savings of about 30% compared to Western European countries and is approximately 50% cheaper than in the USA.
Advantages of Treatment in Israel
- Effectiveness of antitumor therapy.
- Qualification and experience of doctors.
- Modern material and technical base.
- Use of progressive diagnostic and treatment methods.
- Affordable prices.
Modern achievements in medicine and pharmacology allow us to view hemoblastoses not as a death sentence, but as a serious disease requiring timely and comprehensive therapy. Do not waste time, contact your chosen Israeli clinic, and begin treatment as soon as possible.